Hip osteoarthritis
Image-guided intra-articular protocols for hip OA — most useful before joint-replacement candidacy, or for patients seeking to delay or avoid surgery. The hip is a deeper, more technically demanding joint to treat — and the work it does on every step you take.
- Class
- Cartilage · joint
- Approach
- Intra-articular, image-guided
- Materials
- MSC · exosome · PRP
- Imaging
- X-ray + MRI required
01 About
What hip OA is.
Hip osteoarthritis is the progressive degeneration of articular cartilage in the femoroacetabular joint. It usually presents as deep groin pain, stiffness in the morning or after sitting, and reduced range of motion — particularly with internal rotation. Over years, the joint space narrows and bony changes (osteophytes) develop on imaging.
The conventional pathway for hip OA is anti-inflammatories, weight management, physical therapy, and eventually total hip arthroplasty. Regenerative protocols offer a middle option: a targeted intervention for patients with moderate disease who want to push the timeline of surgery out — or whose disease is not yet at the threshold where replacement is the right answer.
02 How it works
How stem cells help the hip.
Mesenchymal stem cells delivered intra-articularly under image guidance modulate the inflammatory environment of the joint, signal to surviving chondrocytes, and release exosomes that drive paracrine repair. The cellular signaling supports the cartilage that remains and reduces the local inflammation that drives pain.
For the hip specifically, accurate image-guided delivery matters more than for any other joint — the femoral head is deep, surrounded by major vessels and nerves, and blind injection is not safe. We use ultrasound guidance for every hip procedure.
03 What the research shows
What the studies show.
Hip OA has fewer published trials than knee OA — partly because the joint is harder to access, partly because hip replacement is a more decisive surgical option. The available evidence, however, is consistently positive in early-to-moderate disease.
-
Management of Hip Osteoarthritis: Harnessing the Potential of Mesenchymal Stem Cells
A 2024 systematic review pooled 10 studies (316 patients) of MSC therapy for hip OA. Five of six prospective studies reported statistically significant improvements in pain (WOMAC, VAS) and function — with no serious adverse events. The strongest data so far for early-stage hip disease.
Read on PubMed Central -
Mesenchymal Stem Cells Injection in Hip Osteoarthritis: Preliminary Results
Adipose-derived MSC injection in patients with early hip OA produced significant clinical improvement on pain and function scores at 6 and 12 months. The protocol was characterized as "simple, economic, quick, minimally invasive, single-staged" with no treatment-related adverse events.
Read on PubMed Central -
Current Evidence on Mesenchymal Stem Cells for Hip Osteoarthritis
A focused narrative review of MSC therapy for hip OA found short- to mid-term improvements in pain and function with favorable safety profiles, while emphasizing that long-term structural outcomes still require larger randomized trials.
Read on Taylor & Francis
Evidence is best for mild-to-moderate hip OA. We will tell you when joint replacement is the better answer — usually when imaging shows bone-on-bone disease and function is severely limited.
04 Are you a candidate
Who's a candidate.
Candidates:
- Imaging-confirmed mild-to-moderate hip OA with persistent groin or lateral hip pain.
- Patients who have plateaued on PT, NSAIDs, and weight-management interventions.
- Patients seeking to delay or avoid total hip replacement, or who are not yet surgical candidates.
- Active adults whose hip pain is limiting walking, sitting, or sleep.
When we will not recommend it:
- Severe end-stage OA where surgery is the appropriate answer.
- Hip dysplasia or femoroacetabular impingement requiring surgical correction.
- Avascular necrosis of the femoral head with significant collapse.
- Patients without recent imaging — we do not inject the hip blind.
Think you might be a candidate?
The first step is a 60–90 minute consultation. We review your imaging, history, and goals — and tell you honestly whether regenerative therapy is the right next step.
05 A patient experience
Dr. Abdullah is the doctor you'll want to have. Patient, calm, listens attentively. I'll wholeheartedly recommend this place to my family and loved ones.
Mickhail Bobga Google · 5.0
07What happens at your consultation
A conversation, not a sales meeting.
-
01
Intake & history
60–90 minutes. We review imaging, prior treatments, current medications, and goals. Most of this hour is listening.
-
02
Focused exam
A clinical exam tailored to your indication. Range of motion, strength, functional testing — what the literature actually predicts response on.
-
03
Honest candidacy review
If we think you're a candidate, we'll tell you why. If we don't, we'll tell you what we'd recommend instead — surgery, PT, watchful waiting.
-
04
Written plan & pricing
A defined treatment plan with modality, sequence, follow-up cadence, and total cost — before any commitment.
06 What treatment looks like
What treatment looks like.
A typical hip protocol begins with a 60–90 minute consultation, recent X-ray and MRI review, and labs. Treatment is a single in-clinic session — image-guided intra-articular delivery of cellular and exosome material into the joint capsule. Patients are usually back to gentle walking the same day.
Reassessment occurs at three months, six months, and one year, with functional testing and (if indicated) repeat imaging. We adjust the protocol on what we observe — adjunct shockwave for surrounding tendons, a repeat dose, or a referral for surgical evaluation if the response is insufficient.
09 Common questions
Common questions, answered.
Can this delay hip replacement?
In mild-to-moderate hip OA, yes — often by years, with meaningful function gains. In end-stage bone-on-bone disease, replacement is usually the better answer and we'll tell you that honestly.
Why is image guidance critical for the hip?
The femoral head is deep and surrounded by major vessels and nerves. Blind injection isn't safe. Every hip procedure at Apex uses ultrasound guidance.
How long is recovery?
Same-day discharge, light activity within 24 hours, full activity within a week. Most patients walk out of the clinic comfortably.
How many sessions will I need?
Typically a single session, with reassessment at 3 months. A repeat dose is occasionally indicated for select patients.
When will I see results?
Modest improvement at 6–8 weeks, full response at 3–6 months. We track progress at defined reassessment points.
What are the risks or side effects?
Mild post-injection soreness for 48–72 hours is the most common. Serious adverse events are rare with screened allogeneic material under image guidance.
08 Coverage & cost
Most regenerative protocols at Apex are not covered by insurance — we discuss pricing directly, in writing, before any commitment. Softwave shockwave is the exception: covered by Medicare Parts A & B with supplement (not by Medicare Advantage). Financing options are available for protocols not covered. We never hold a pricing conversation until we know you're a candidate.
Begin with a consultation.
A conversation about your hip, your imaging, and whether stem cell or exosome therapy is the right tool — and what we'd recommend if it isn't.